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Chapter 1. In this thesis an investigation into the pathogenetic mechanisms
of epimembranous immune complex deposition in the glomeruli was describ'
ed. For this study we used two related models of experimental immune
complex glomerulonephritis: the heterologous and the autologous immune
complex glomerulonephritis. The "natural history" of these two models was
compared and the effect of some factors which influenced the deposition of
immune complexes in the GBM were studied. These factors were:
l. a treatment with a combination of immunosuppressive drugs and pred-
nisolone.
2. injections of the constituents of immune complexes, i.e. antigen or
antibody.
3. an induction of increased permeability of the GBM by aminonucleoside
of puromycin.
In chapter II the "natural history" of the autologous immune complex
glomerulonephrit is was described. Immunisation with FxlA antigens from
the kidney resulted in a granular deposition of immune complexes containing
rat IgG along the GBM, 6 weeks after the start of the immunisation. The
immune complexes were deposited at the epithelial side of the GBM and
were growing in size and number during the course of the disease. However
in no phase of the disease a transit of immune complexes through the GBM
could be detected at the ultrastructural level. It was thought that probably a
separate transit of antibody and antigen through the GBM took place and
that the immune complexes were formed at the epithelial side of the GBM.
This theory was supported by the fact that free circulating anti-Fx1A antibody
seemed to have pathogenetic significance. The rise in serum titer of anti-Fxl A
antibody at week 9 coincided with the start of the proteinuria.
Furthermore we were able to transfer the disease into normal rats using serum
of rats with autologous immune complex glomerulonephritis containing tree
ant i -Fx lA ant ibodies.
The only reaction of the glomeruli to the continuous presence of immune
complexes along the GBIvI was a formation of basement membrane like
material, resulting in "spikes". At the end of the observation period the
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deposits were subject to resolution, which was associated with a disappearance
of rat anti-Fx1A antibodies from the serum. However the proteinuria
persisted, probably because of the damage to the GBM.
In late stages of the autologous immune complex glomerulonephritis multiple
tubular adenomas were found in contrast to normal animals o{ the same age,
in which sometimes a large single tubular adenoma was seen. It was reasoned
that the multiplicity of the adenomas probably was caused by the "workload"
of the tubules as a result of the high protein leakage from the glomeruli.
ln chapter III the "natural history" of the heterologous immune complex
glomerulonephritis was described. This heterologous model was induced by
a single intraperitoneal or intravenous injection of rabbit antibodies directed
against FxlA antigens. Because a heterologous protein was injected the
animal made antibodies to this protein, resulting in an autologous phase. In
no disease stage proteinuria was found. Like in the autologous model immune
complexes were present underneath the epithelial cells and in the filtration
slits, but were never observed in other layers of the GBM. Only during the
first 7 days it was possible to transfer the disease into normal rats, because
only in this period rabbit anti-FxlA antibody was present in the circulation.
Autologous (rat) antibody directed against rabbit IgG was present in the
circulation from day 7 until week 24. After this moment a resolution of
depositions in the GBM started. Embedding in GBM-like material gave the
impression that the aggregates were moving towards the endothelial side of
the GBM, although at all times the dense layer of the original GBM could
be found underneath the aggregates.
Like in normal rats, animals with heterologous immune complex glomerulo-
nephritis showed large single tubular adenomas of the kidneys in late disease
stages. This finding supported the "workload" hypothesis as described in
chapter II, because no proteinuria was found in the heterologous immune
complex glomerulonephritis.
In chapter IV a review of the literature was given on possibilities to influence
an immune complex glomerulonephrit is and a general design for the experi-
ments was presented.
Treatment with immunosuppressive drugs and prednisolone.
From the literature it may be concluded that although immunosuppressive
and anti inflammatory therapy are often used in glomerulonephritis only
a few cases seem to benefit from these drugs. In this study a combination
of immunosuppressive drugs and anti inflammatory drugs was chosen to
influence the immune complex glomerulonephritis.
- In human as well as in experimental immune complex glomerulonephritis
it is reported that immune complex aggregates may disappear from the
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GBM, when antigen or antibody involved disappears from the circulation.
Therefore injections of antigen and antibody might influence immune
complex glomerulonephrit is through changing the composition of the
circulating immune complexes.
This immunotherapy was only used in experimental models and it was
reported that in the BSA anti-BSA system in rabbits an accelerated
disappearance of immune complex aggregates from the GBM was
observed following injections of BSA. In our experiments we studied the
influence of injections of extra antigen or antibody given either to prevent
deposition of immune complexes in the GBM or to accelerate the
resolution of immune complexes deposited in the GBM.
- Some literature was presented on the fi l tration process of the GBM and
the specific influence of PAN on this l i l tration. Because in our model the
first deposition of immune complexes appeared always in the filtration
slits of the GBM, PAN was used to increase the permeabil ity either to
prevent the deposition of immune complexes or to accelerate their
disappearance from the GBM.
In chapter V the influence of the above mentioned factors on the heterologous
immune complex glomerulonephrit is was decribed. Although triple drug
treatment did not influence the deposition of rabbit IgG in the GBM, the
autologous phase was clearly influenced. Using treatrnent with high dose
schedules, this phase could be suppressed completely.
Immunotherapy using injections of extra antibody resulted in an increased
deposition of immune complexes in the GBM, associated with a transient
proteinuria. Injections of extra antigen prevented immune complex deposition
in the GBM completely when given just before or after the induction of the
disease. High doses of antigen administration resulted in a deposition of
rabbit IgG in the mesangium of the kidney.
Increased permeabil ity of the GBM at the moment of the induction of the
disease, prevented the deposition of immune complexes in the GBM. Some
rabbit IgG was present on the brushborders of the proximal tubules.
Increased permeability of the GBM after the induction of the disease seemed
to have no influence on the deposits already present in the GBM.
In chapter VI the results of the studies on factors influencing the autologous
immune complex glomerulonephritis were described.
Triple drug treatment could prevent the deposition of immune complexes in
the GBM, when this treatment was started simultaneously with the immuni-
sation of the rats. The influence of triple drug treatment was less marked
when given on a moment at which immune complexes were present in the
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GBM. In later phases of the disease when proteinuria was fully developed,
no beneficial effect of triple drug treatment was observed at all.
Immunotherapy using injections of extra antibody resulted in an increase in
deposition of immune complexes in the GBM. This increase was caused
mainly by the deposition of rat IgG along the GBM. Electron microscopy
revealed that in these cases the electron lucent areas around the deposits were
filled again with dense material, probably through an immune reaction of the
animal causing deposition of rat anti-rabbit IgG antibody. Injections of extra
FxlA antigen seemed to have no effect on the amount of deposited immune
complexes in the GBM and on the resulting proteinuria.
Administration of PAN at low doses during an early observation period,
seemed to decrease the amount of deposits in the GBM. PAN injections in
late stages of the disease when proteinuria was present, caused ascites and
death of the animals. Like in the heterologous immune complex glomerulo-
nephritis no effect was noted on depositions already present in the GBM.
The effect of PAN on the deposition of immune complexes in the GBM
seemed not directly related to the amount of proteinuria induced by PAN.
In chapter VII the facts from previous chapters which were of importance
for a better understanding of the pathogenesis of the heterologous and
autologous immune complex glomerulonephrit is were discussed. In both
models the deposition of immune complexes at the epithelial side of the GBM
seemed to be related to the presence in the serum of antibodies participating
in the formation of immune complexes. In later stages of the disease resolution
of immune complex aggregates coincided with the disappearance of anti-
bodies from the serum which participated in immune complex formation. The
proteinuria, which was present in the autologous model and absent in the
heterologous immune complex glomerulonephritis, seemed to be related to
the amount of immune complex depositions in the GBM rather than to the
binding and activation of complement.
The results from previous chapters were reviewed leading to the hypothesis
that not immune complex aggregates derived from the circulation were
deposited in the GBM, but that immune complex deposition resulted rather
from a separate transit of antibody and antigen through the GBM. Since this
hypothesis was not in agreement with the results of injections of extra rabbit
anti-Fx1A antibody in heterologous immune complex glomerulonephritis,
the possibility was considered that FxlA antigens were present in the GBM as
an integral part of the capillary wall. Immunohistology at the light micro-
scopic level and the ultrastructural level using heterologous anti-Fx1A anti-
body, indeed demonstrated the presence of these antigens within the cell
coat of epithelial cells of the glomeruli, beneath the foot processes and
within the filtration slits.
This led to the concept that in these models of experimental glomerulo-
nephritis a fixed antigen is a central feature in the pathogenesis of immune
complex deposition. The implications of this finding for other forms of
experimental glomerulonephritis and human glomerulonephritis were
discussed and it was concluded that binding of antibody to these fixed
antigens might present all the morphological and immunohistological
features of glomerular immune complex disease.
In chapter VIII materials and methods were presented.
